We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

479 hedge funds and large institutions have $27.5B invested in Vertex Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 194 increasing their positions, 155 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 47

25% more repeat investments, than reductions

Existing positions increased: 194 | Existing positions reduced: 155

1% more funds holding

Funds holding: 474 → 479 (+5)

1% more capital invested

Capital invested by funds: $27.3B → $27.5B (+$279M)

17% less call options, than puts

Call options by funds: $80.4M | Put options by funds: $97.3M

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
479
Holders Change
+5
Holders Change %
+1.05%
% of All Funds
12.77%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
62
Increased
194
Reduced
155
Closed
47
Calls
$80.4M
Puts
$97.3M
Net Calls
-$16.9M
Net Calls Change
+$182M

Top Buyers

1
MCM
Marsico Capital Management
Colorado
+$259M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
+$222M
3
UBS AM
UBS AM
Illinois
+$157M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$121M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$113M

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$238M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$220M
3
O
OrbiMed
New York
-$191M
4
Capital World Investors
Capital World Investors
California
-$139M
5
Millennium Management
Millennium Management
New York
-$79.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
201
Shell Asset Management
Netherlands
$4.68M -$1.23M -10,225 -20%
ERSOT
202
Employees Retirement System of Texas
Texas
$4.6M -$120K -1,000 -3%
GH
203
GAM Holding
Switzerland
$4.43M -$841K -7,017 -16%
Nomura Asset Management
204
Nomura Asset Management
Japan
$4.39M +$414K +3,455 +10%
AAM
205
Advisors Asset Management
Colorado
$4.39M +$1.11M +9,261 +33%
LMIM
206
Lockheed Martin Investment Management
Maryland
$4.28M +$4.35M +36,300 New
PNC Financial Services Group
207
PNC Financial Services Group
Pennsylvania
$4.26M +$247K +2,061 +6%
OTPPB
208
Ontario Teachers' Pension Plan Board
Ontario, Canada
$4.15M +$245K +2,042 +6%
NMIMC
209
Northwestern Mutual Investment Management Company
Wisconsin
$4.12M +$4.19M +34,952 New
MOACM
210
Mutual of America Capital Management
New York
$3.92M +$157K +1,311 +4%
OPPM
211
Opus Point Partners Management
New York
$3.87M +$444K +3,709 +13%
Mitsubishi UFJ Asset Management
212
Mitsubishi UFJ Asset Management
Japan
$3.81M -$179K -1,491 -4%
3NC
213
300 North Capital
California
$3.75M +$515K +4,299 +16%
MSA
214
Mason Street Advisors
Wisconsin
$3.68M -$16.3M -135,867 -81%
CM
215
Castleark Management
Illinois
$3.64M – – –
OI
216
Oakbrook Investments
Illinois
$3.57M +$1.47M +12,275 +68%
Envestnet Asset Management
217
Envestnet Asset Management
Illinois
$3.57M +$3.6M +30,062 +15,822%
PCMI
218
Princeton Capital Management Inc
New Jersey
$3.45M -$163K -1,360 -4%
Point72 Asset Management
219
Point72 Asset Management
Connecticut
$3.44M +$1.52M +12,700 +77%
CPS
220
Counsel Portfolio Services
Ontario, Canada
$3.42M +$3.47M +28,949 New
VKH
221
Virtu KCG Holdings
New York
$3.4M +$3.46M +28,842 New
CIBC Asset Management
222
CIBC Asset Management
Ontario, Canada
$3.33M +$246K +2,054 +8%
ACM
223
Arlington Capital Management
Illinois
$3.31M +$306K +2,557 +10%
NMERB
224
New Mexico Educational Retirement Board
New Mexico
$3.29M -$108K -900 -3%
COPPSERS
225
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.28M -$1.93M -16,113 -37%
7 8
9
10 11

VRTX Hedge Fund Activity: Q1 2015 in Review

479 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q1 2015, worth a combined $27.5B — up 1% from $27.3B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new VRTX positions and 47 closed out — a net gain of 15 holders — while 194 added to existing stakes and 155 trimmed.

The largest buyer was Marsico Capital Management, opening a new position worth an estimated $259M. The largest seller was Vanguard Group, cutting an estimated $238M.

  • 479 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q1 2015, up from 474 in Q4 2014.
  • Funds reported $27.5B of Vertex Pharmaceuticals stock for Q1 2015, up 1% quarter-over-quarter.
  • 62 funds opened new Vertex Pharmaceuticals positions in Q1 2015 and 47 closed out, a net change of +15 holders.
  • The largest Vertex Pharmaceuticals buyer in Q1 2015 was Marsico Capital Management, an estimated $259M added.
  • The largest Vertex Pharmaceuticals seller in Q1 2015 was Vanguard Group, an estimated $238M sold.

Based on aggregated 13F filings for Q1 2015.